Context: Various drugs affect body weight as a side effect. Objective: We conducted this
systematic review and meta-analysis to summarize the evidence about commonly …

Diabetes mellitus type 2 is a world-wide growing health problem affecting more than 150
million people at the beginning of the new millennium. It is believed that this number will …

PURPOSE: To study the efficacy and safety of various dosages of metformin as compared
with placebo in patients with type II diabetes mellitus. PATIENTS AND METHODS: A 14 …

Aims/hypothesis Sulfonylureas are widely prescribed glucose-lowering medications for
diabetes, but the extent to which they improve glycaemia is poorly documented. This …

The sulphonylureas act by triggering insulin release from the pancreatic β cell. A specific site
on the adenosine triphosphate (ATP)-sensitive potassium channels is occupied by …

Introduction This study assessed the safety and efficacy of ertugliflozin (an oral sodium-
glucose cotransporter 2 inhibitor) vs. glimepiride in patients with type 2 diabetes mellitus …

OBJECTIVE—Liraglutide is a long-acting glucagon-like peptide 1 analog designed for once
daily injection. This study assessed the efficacy and safety of liraglutide after 12 weeks of …

Non-insulin-dependent diabetes mellitus (NIDDM, type 2 diabetes) is a heterogeneous
disease resulting from a dynamic interaction between defects in insulin secretion and insulin …

Objective: To review the oral and injectable pharmacologic treatment options for type 2
diabetes. Data Sources: A literature search was conducted using PubMed electronic …

Synopsis Glimepiride is a sulphonylurea agent that stimulates insulin release from
pancreatic β-cells and may act via extrapancreatic mechanisms. It is administered once daily …